Does SECUKINUMAB Cause Product dose omission issue? 4,572 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 4,572 reports of Product dose omission issue have been filed in association with SECUKINUMAB (COSENTYX). This represents 3.0% of all adverse event reports for SECUKINUMAB.
4,572
Reports of Product dose omission issue with SECUKINUMAB
3.0%
of all SECUKINUMAB reports
22
Deaths
319
Hospitalizations
How Dangerous Is Product dose omission issue From SECUKINUMAB?
Of the 4,572 reports, 22 (0.5%) resulted in death, 319 (7.0%) required hospitalization, and 31 (0.7%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SECUKINUMAB. However, 4,572 reports have been filed with the FAERS database.
What Other Side Effects Does SECUKINUMAB Cause?
Drug ineffective (27,434)
Psoriasis (21,976)
Pain (15,244)
Arthralgia (13,769)
Fatigue (9,406)
Psoriatic arthropathy (8,900)
Pruritus (8,755)
Malaise (8,570)
Rash (8,023)
Condition aggravated (7,536)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
APREMILAST (4,460)
GOLIMUMAB (4,216)
Which SECUKINUMAB Alternatives Have Lower Product dose omission issue Risk?
SECUKINUMAB vs SELADELPAR LYSINE
SECUKINUMAB vs SELEGILINE
SECUKINUMAB vs SELENIUM
SECUKINUMAB vs SELENIUM SULFIDE
SECUKINUMAB vs SELEXIPAG